Diabetes Technology Society (DTS) 2010

November 2010

Acute Pulmonary Effects of Technosphere^® Insulin Inhalation Powder Administered Using a Gen2B Inhaler Compared to a MedTone^® C Inhaler
Authors: Nikhil Amin, MD; Mark T. Marino, MD; James P. Cassidy, MS; Hao Ren, MS; Russell L. Harris, MBA, RPFT, CRT; Peter C. Richardson, MD

2010 DTS Poster 141 FEV1

Bioequivalence and Dose Proportionality of AFREZZA^® Inhalation Powder Administered Using a Gen2 Inhaler Compared to the MedTone^® Inhaler
Authors: Mark T. Marino, MD; James P. Cassidy, MS; Chad C. Smutney, BSME; Michael Zupon, PhD; Joseph Kocinski, PhD

2010 DTS Poster 142 BE

The Relationship Between Two Insulin Assays Used to Determine Bioequivalence and Dose Proportionality of AFREZZA^® Insulin Administered Using a Gen2 Inhaler Compared to a MedTone^® Inhaler: Simulation of Clinical Trials and Actual Data
Authors: Mark T. Marino, MD and James P. Cassidy, MS

2010 DTS Poster 141 RIA

Handleability and Characterization of Inhalation Profiles Using the Gen2 Delivery System in a Pediatric Population
Authors: Christine C. Billings; Chad C. Smutney, BSME; Campbell P. Howard, MD; John M. Polidoro, MS

2010 DTS Poster 143 Peds